Table 2.
Events of treatments | Prolonged recoverya
|
P value | |
---|---|---|---|
No (n=477)b | Yes (n=304)c | ||
Respiratory-specific events | 6 (1.3) | 29 (9.5) | <0.001 |
Postoperative nausea and vomiting | 92 (19.3) | 106 (34.9) | <0.001 |
Intravenous morphine equivalents, median (interquartile), mg | 5.0 (0.0–10.5) | 10.0 (3.0–15.0) | <0.001 |
Antihypertensive medication administrationd | 33 (6.9) | 49 (16.1) | <0.001 |
Vasopressor medication administratione | 0 | 2 (0.7) | 0.15 |
Values are presented as number and percentage of patients unless specified otherwise
Phase I postanesthesia recovery ≤90 min
Phase I postanesthesia recovery >90 min
Hydralazine was administered to 3 patients discharged in ≤90 min and to 13 patients discharged in >90 min. Labetalol was administered to 43 vs 29 patients and metoprolol to 2 vs 2 patients in the groups discharged in ≤90 vs >90 min, respectively
Phenylephrine boluses were administered to 2 patients